Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study. (Q35880368)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

1 January 2020

title

Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

1 January 2020

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Daryl Freeman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

1 January 2020

Angela Lee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

1 reference

2 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

1 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

COPD exacerbations: the importance of a standard definition

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Detection of asthma and chronic obstructive pulmonary disease in primary care

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Raising awareness of COPD in primary care

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Standardization of Spirometry, 1994 Update. American Thoracic Society

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913915

Questions for COPD diagnostic screening in a primary care setting

11 July 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-45

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-45

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-45

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-45

Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-45

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-45

The functional impact of adding salmeterol and tiotropium in patients with stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-45

Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1465-9921-8-45

Role of the parasympathetic system in airway obstruction due to emphysema

21 January 2018

1 reference

12 December 2020

Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease

1 reference

12 December 2020

Reliability and validity of dyspnea measures in patients with obstructive lung disease

1 reference

12 December 2020

[Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]

1 reference

12 December 2020

Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma

1 reference

12 December 2020

[Lung volumes and forced ventilatory flows. Work Group on Standardization of Respiratory Function Tests. European Community for Coal and Steel. Official position of the European Respiratory Society]

1 reference

12 December 2020

BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS

1 reference

12 December 2020

Tiotropium in COPD patients not previously receiving maintenance respiratory medications

1 reference

12 December 2020

Identifiers

DOI

10.1186/1465-9921-8-45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17605774 AND SRC:MED&resulttype=core&format=json

1 January 2020

PubMed publication ID

17605774

1 reference